720-777-0123
- Your Visit
-
Research & Innovation
It starts with a Q:
For the latest cutting-edge research, innovative collaborations and remarkable discoveries in child health, read stories from across all our areas of study in Q: Advances and Answers in Pediatric Health.
The privilege of being a part of a patient’s and family’s lives at such a difficult time is something that I take very seriously. While my ultimate goal as an oncologist is to cure my patients of their cancers, I strongly believe in the importance of considering each child and family's whole experience through this difficult journey. It is our duty to work toward reducing harmful side effects both during and after treatment and I strive to consider these short and long term effects at every interaction.
Get to know Jenna Demedis, MD
My focus is on taking care of children, adolescents and young adults with pediatric solid tumors of all types, as well as caring for survivors of pediatric cancers.
Undergraduate 2008
University of California–Los Angeles (CA)
Medical Education 2012
Vanderbilt University School of Medicine
Residency 2015
University of Colorado (Children's Hospital Colorado) Program
Graduate 2018
University of Colorado Denver
Fellowship 2018
University of Colorado (Children's Hospital Colorado) Program
For Patients:
My research interests are in pediatric oncology outcomes, late effects, and patient quality of life.
My research interests are in pediatric oncology outcomes, late effects, and patient quality of life.
For Referring Providers:
My research interests are in pediatric oncology outcomes, late effects, and patient quality of life. Specifically, my research has focused on abnormal glucose control in the pediatric oncology and bone marrow transplantation population, as well as on describing adverse acute and late effects of emerging therapeutics. I am actively exploring opportunities for research within the cancer survivorship realm as well.
My research interests are in pediatric oncology outcomes, late effects, and patient quality of life. Specifically, my research has focused on abnormal glucose control in the pediatric oncology and bone marrow transplantation population, as well as on describing adverse acute and late effects of emerging therapeutics. I am actively exploring opportunities for research within the cancer survivorship realm as well.
Kelly Faulk, MD
Hematology/Oncology - Pediatric, Pediatrics
Kristen Eisenman, MD
Hospice & Palliative Medicine, Hematology/Oncology - Pediatric, Pediatrics
